In vivo assessment of mutations in OTC for dominant-negative effects following rAAV2/8-mediated gene delivery to the mouse liver.

Autor: Ginn, S. L.1, Cunningham, S. C.1, Zheng, M.1, Spinoulas, A.1, Carpenter, K. H.2,3, Alexander, I. E.1,3 iana@chw.edu.au
Zdroj: Gene Therapy. Jun2009, Vol. 16 Issue 6, p820-823. 4p. 1 Diagram, 3 Graphs.
Databáze: Academic Search Ultimate